# 一茶匙蜂蜜極大提升風味。

*biotech · news · 2026-06-09 · STAT*

## Key points

- GSK以106億美元收購Nuvalent，為多年來最大交易。
- Nuvalent有兩款針對非小細胞肺癌的癌症療法目前正接受FDA審查。
- 兩款Nuvalent療法今年皆有望獲得FDA批准。
- 此收購將大幅擴展GSK在肺癌治療領域的布局。

Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. Who could ask for anything more? Actually, we could — it is time to reheat the kettle for another cuppa stimulation. Our choice today is raspberry hibiscus. And here is a helpful tip: A teaspoon of honey enhances the flavors splendidly. Of course, you are invited to join us. For the full experience, we are hawking replicas — take a look. Meanwhile, here are a few tidbits to help you along. As always, do keep in touch. We appreciate feedback, criticism, and tips. … GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology, STAT writes. The deal is the latest in a run of biopharma acquisitions in recent months, as large and even midsize companies have been looking to bolster their pipelines as some of their key products face looming generic competition. This latest deal is one of the largest in the recent buying spree, and GSK’s largest in years. Nuvalent designs targeted cancer therapies, with two molecules both under U.S. Food and Drug Administration review for types of non-small cell lung cancer. They could be approved this year. The deal will give GSK, which has focused on gynecologic cancers as well as multiple myeloma, a broader lung cancer portfolio. Advertisement

**Companies:** GSK, Nuvalent
**Countries:** United Kingdom, United States

[Read the full story on STAT](https://www.statnews.com/pharmalot/2026/06/09/gsk-buying-nuvalent-cancer-drug-astrazeneca-obesity-pill-data/)

---

Canonical: https://newsio.io/zh-TW/n/4d8ad7e2-81db-4d08-89f5-66139abd41ca/
Summarized by Newsio from STAT. https://newsio.io/how-it-works